University of Michigan Health announced it will no longer provide puberty blockers or gender-affirming hormones to patients under 19 years old due to legal and regulatory threats.
UM Health has received a federal subpoena as part of a criminal and civil investigation into gender-affirming care.
In response, UM Health said it will increase access to mental health services for patients impacted.
Patients ages 19 and older are not affected by this change.
The University of Michigan, including Michigan Medicine, is one of multiple institutions across the country that has received a federal subpoena as part of a criminal and civil investigation into gender-affirming care for minors. In light of that investigation, and given escalating external threats and risks, we will no longer provide gender affirming hormonal therapies and puberty blocker medications for minors.
We recognize the gravity and impact of this decision for our patients and our community. We are working closely with all those impacted, and we will continuously support the well-being of our patients, their families, and our teams.
We are deeply grateful to our clinicians for their unyielding commitment to providing the highest quality care, and to all of our team members for their dedication to helping our patients, and to supporting each other, as we navigate these changes together.
Click this link for the original source of this article.
Author: Dillon B
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
